Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

postpartum hemorrhage/diarrea

L'enllaç es desa al porta-retalls
Pàgina 1 des de 16 resultats
BACKGROUND The Postpartum bleeding is the first cause of maternal mortality in Morocco. It is an obstetrical emergency that requires a fast multimodal management including medical care, interventional procedure and in few cases a salvatory surgery. METHODS We report a rare case of uterine necrosis

Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Introduction: obstetric hemorrhage is estimated to cause 25% of all maternal deaths and is the leading direct cause of maternal mortality worldwide. The World Health Organization recommended the use of uterotonics that should be offered
OBJECTIVE To investigate the side effects of 600 microg oral misoprostol given for the mother and the newborn to prevent postpartum hemorrhage (PPH). METHODS One thousand six hundred twenty women delivering at home or subcentres in rural India were randomised to receive misoprostol or placebo in the

[Risk factors of postpartum hemorrhage during labor and clinical and pharmacological prevention].

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Prevention of postpartum hemorrhage (PPH) is a major concern in regards to its impact on maternal morbidity and mortality. While established risk factors can be identified among risk factors of PPH during labor after multivariate analysis: prolonged labor, oxytocin stimulation of labor, cesarean

Management of severe postpartum hemorrhage due to uterine atony using an analogue of prostaglandin F2 alpha.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Twenty patients with severe postpartum hemorrhage due to uterine atony who were unresponsive to conventional therapy were treated with 0.25-mg intramuscular injections of (15-S)-15-methyl prostaglandin F2 alpha-tromethamine. A rapid and successful response was obtained in 18 patients. Two patients

Oral misoprostol for third stage of labor: a randomized placebo-controlled trial.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
OBJECTIVE To investigate whether orally administered misoprostol during the third stage of labor is efficient in reducing postpartum blood loss. METHODS In a double-masked trial, during vaginal delivery women were randomly assigned to receive a single oral dose of misoprostol (600 microg) or placebo

Termination of second-trimester pregnancy with intracervicovaginal misoprostol.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
To evaluate the efficacy and side effects of intracervicovaginal misoprostol in termination of second-trimester pregnancy in women with live fetuses. A total of 50 pregnant women between 14 and 27 week's gestation undergoing termination of pregnancy for medical, obstetrical and genetic reasons were
OBJECTIVE To compare the efficacy of oral misoprostol with that of oxytocin for active management of the third stage of labor (AMTSL). METHODS A double-blind randomized control trial was undertaken at a center in Ilorin, Nigeria, between January and June 2013. Every other eligible patient (in the

Carboprost Versus Oxytocin for Active Management of Third Stage of Labor: A Prospective Randomized Control Study.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
OBJECTIVE Postpartum hemorrhage is the single largest and leading cause of maternal morbidity and mortality not only in developing countries but also in developed countries. The present study is an attempt to evaluate the scope of using prophylactic intramuscular carboprost tromethamine 125 μg in
OBJECTIVE To compare the efficacy and side effects of 0.2 mg methyl-ergometrine IM, 400 microg misoprostol sublingual and 125 microg 15 methyl PGF2alpha IM in active management of third stage of labor. METHODS Two hundred low risk pregnant women with induced or spontaneous labor were randomized to
The dried fruit of Evodia rutaecarpa (Juss.) Benth. (ER) is a well-known traditional Chinese medicine and has been used in treatment of headache, abdominal pain, migraine, chill limbs, diarrhea, nausea, hyperbaropathy, dysmenorrheal and postpartum hemorrhage. In this work, a comprehensive

Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
OBJECTIVE To compare the efficacy, side effects, and complications of high-dose vaginal misoprostol with concentrated intravenous oxytocin plus low-dose vaginal prostaglandin (PGE(2)) for second-trimester labor induction. METHODS One hundred twenty-six consenting women with maternal or fetal

Profound Hyperthermia After Postpartum Rectal Misoprostol Administration.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND Misoprostol, a synthetic prostaglandin E1 analog, is commonly used for treatment and prevention of postpartum hemorrhage. Known side effects include transient hyperthermia, chills, nausea, vomiting, and diarrhea. METHODS After a precipitous vaginal delivery complicated by postpartum

The use of misoprostol in termination of second-trimester pregnancy.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Misoprostol, a synthetic prostaglandin E1 analog, is initially used to prevent peptic ulcer. The initial US Food and Drug Administration-approved indication in the product labeling is the treatment and prevention of intestinal ulcer disease resulting from nonsteroidal anti-inflammatory drugs use. In
BACKGROUND Transfusion-transmissible infections (TTIs) pose a major health risk in Cameroon given the high prevalence of such pathogens and increased demands for blood donations in the local communities. This study aims at establishing the prevalence of commonly encountered TTIs among blood donors
Uneix-te a la nostra
pàgina de Facebook

La base de dades d’herbes medicinals més completa avalada per la ciència

  • Funciona en 55 idiomes
  • Cures a base d'herbes recolzades per la ciència
  • Reconeixement d’herbes per imatge
  • Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
  • Llegiu publicacions científiques relacionades amb la vostra cerca
  • Cerqueu herbes medicinals pels seus efectes
  • Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades

Google Play badgeApp Store badge